Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599492 · ClinicalTrials.gov registry record
The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut Microbiota
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 14
- Enrollment target
NCT03599492 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 14 participants.
The verdict
NCT03599492 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
The effect of portal hypertension on gastrointestinal motility, and how reversal or improvement in portal hypertension may alter gastrointestinal motility, remains unclear and further research is needed. Additionally, patients with cirrhosis have altered gut microflora, particularly rich in lactobacilli, including enterococci and bifidobacteria. Transjugular Intraheptic Portosystemic Shunting (TIPS) is a procedure performed by interventional radiologists, in which a connection is made between the portal and venous circulations, allowing high pressure portal blood to more easily enter the systemic circulation and bypass the liver; thus effectively decreased portal pressure.
Interventions
- DIAGNOSTIC_TEST SMART Pill Pre-TIPS
- DIAGNOSTIC_TEST SMART Pill Post TIPS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-11 |
| Est. Completion | 2022-04-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03599492
The ClinicalTrials.gov registry entry for NCT03599492 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SMART Pill Pre-TIPS is the first listed.
NCT03599492 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03599492 about?
NCT03599492 is a clinical study titled "The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut Microbiota". The effect of portal hypertension on gastrointestinal motility, and how reversal or improvement in portal hypertension may alter gastrointestinal motility, remains unclear and further research is needed. Additionally, patients with cirrhosis have altered gut microflora, particularly rich in lactobac...
What is the current status of trial NCT03599492?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2016-11. Estimated completion is 2022-04-12.
What interventions are being tested in trial NCT03599492?
The interventions under investigation include: SMART Pill Pre-TIPS (DIAGNOSTIC_TEST), SMART Pill Post TIPS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03599492?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.